Last reviewed · How we verify
Plasmodium falciparum sporozoite challenge — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
Plasmodium falciparum sporozoite challenge (Plasmodium falciparum sporozoite challenge) — Medicines for Malaria Venture.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Plasmodium falciparum sporozoite challenge TARGET | Plasmodium falciparum sporozoite challenge | Medicines for Malaria Venture | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Plasmodium falciparum sporozoite challenge CI watch — RSS
- Plasmodium falciparum sporozoite challenge CI watch — Atom
- Plasmodium falciparum sporozoite challenge CI watch — JSON
- Plasmodium falciparum sporozoite challenge alone — RSS
Cite this brief
Drug Landscape (2026). Plasmodium falciparum sporozoite challenge — Competitive Intelligence Brief. https://druglandscape.com/ci/plasmodium-falciparum-sporozoite-challenge. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab